Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | MGLL | Q99685 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA3 | P07451 | 1/20 | 0.36 |
| ▸ | CA4 | P22748 | 1/20 | 0.36 |
| ▸ | CA6 | P23280 | 1/20 | 0.36 |
| ▸ | CA5A | P35218 | 1/20 | 0.36 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.36 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.36 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| N,N-Dimethylethanaminium SCHEMBL352062 | 1.00 | — | — | |
| N,N-Dimethylethanaminium SCHEMBL16338 | 1.00 | — | — | |
| N,N-Dimethylethanaminium SCHEMBL2382280 | 0.94 | — | — | |
| N,N-Dimethylethanaminium SCHEMBL321085 | 0.94 | — | — | |
| N,N-Dimethylethanaminium SCHEMBL435643 | 0.94 | — | — | |
| N,N-Dimethylethanaminium SCHEMBL1533641 | 0.94 | — | — | |
| N,N-Dimethylethanaminium SCHEMBL6577702 | 0.94 | — | — | |
| N,N-Dimethylethanaminium SCHEMBL1715680 | 0.94 | — | — | |
| N,N-Dimethylethanaminium SCHEMBL672490 | 0.94 | — | — | |
| N,N-Dimethylethanaminium SCHEMBL1191100 | 0.94 | DNM1 (0.33) | TSHRALDH1A1MGLLTDP1CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120292563-A1 | PROCESS FOR PRODUCING CARBON NANOTUBES CONTAINING HYDROXYALKYL ESTER GROUPS AND MATERIALS AND DISPERSIONS CONTAINING SAID CARBON NANOTUBES | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2012-11-22 | — | — | US | disclosed |
| EP-2523902-A1 | PROCESS FOR THE PREPARATION OF CARBON NANOTUBES HAVING HYDROXYALKYL ESTER GROUPS, AND MATERIALS AND DISPERSIONS CONTAINING THESE CARBON NANOTUBES | Bayer Intellectual Property GmbH (DE) | 2012-11-21 | — | — | EP | disclosed |
| WO-2011086049-A1 | PROCESS FOR THE PREPARATION OF CARBON NANOTUBES HAVING HYDROXYALKYL ESTER GROUPS, AND MATERIALS AND DISPERSIONS CONTAINING THESE CARBON NANOTUBES | BAYER MATERIALSCIENCE AG (DE) | 2011-07-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120292563-A1 | PROCESS FOR PRODUCING CARBON NANOTUBES CONTAINING HYDROXYALKYL ESTER GROUPS AND MATERIALS AND DISPERSIONS CONTAINING SAID CARBON NANOTUBES | HACD3, EPHX2, ALKBH3 | TSHR 4820/4885ALDH1A1 353/4885MGLL 1454/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.